Services — Medical Weight Loss
Weight loss that starts
with why — not willpower
Sustainable weight loss isn’t a discipline problem. It’s a biology problem. Our medically supervised program identifies and addresses the metabolic, hormonal, and gut-driven factors that make weight loss difficult — then supports your body with clinically proven tools to produce results that last.
Why most weight loss programs fail
You haven't failed the diet. The approach has failed you.
Weight is a symptom. What drives it — visceral fat accumulation, insulin resistance, metabolic syndrome, hormonal imbalance, and gut dysfunction — are the conditions worth treating. When those underlying factors are addressed with clinical precision, weight loss becomes a measurable, sustainable outcome rather than a constant, exhausting struggle against your own biology.
Root causes we address
Three biological drivers of chronic weight gain
Most weight loss programs ignore these entirely. We start here — because until the underlying biology is addressed, no amount of dietary restriction produces lasting results.
The connections most programs miss
Gut health and hormones — the hidden weight drivers
Beyond the three primary metabolic drivers, two frequently overlooked factors determine whether weight loss is physiologically achievable — and whether it can be maintained.
Medication options
Semaglutide & tirzepatide — how they work
Kiley prescribes the medication appropriate for your clinical presentation, metabolic profile, and goals. These are not interchangeable — each has a distinct mechanism and patient profile.
GLP-1 Agonist
Semaglutide
GLP-1 receptor agonist · weekly injection
Semaglutide mimics the GLP-1 hormone — a naturally occurring incretin released after eating. It acts on GLP-1 receptors in the hypothalamus to reduce appetite and food intake, slows gastric emptying to extend satiety, and improves insulin secretion in response to glucose. Clinical trials demonstrate average weight loss of 15% of body weight alongside meaningful improvements in cardiovascular risk markers, blood pressure, and inflammatory burden.
Dual GIP / GLP-1 Agonist
Tirzepatide
Dual GIP + GLP-1 receptor agonist · weekly injection
Tirzepatide is the first dual GIP and GLP-1 receptor agonist — engaging two distinct hormonal pathways simultaneously. GIP receptor activation provides additional insulin sensitization and fat metabolism effects that GLP-1 alone does not produce. The combined action results in superior metabolic outcomes compared to GLP-1 monotherapy, with clinical trials demonstrating average weight loss of 20–22% of body weight — the highest of any approved pharmacological intervention to date.
Commercial weight loss programs
Caloric restriction without metabolic assessment
No evaluation of hormonal or gut drivers
No clinical oversight or lab monitoring
Medication prescribed without broader program
High recidivism — weight returns when program ends
vs
Our medical weight loss program
Root-cause metabolic, hormonal & gut evaluation
Lab work ordered and interpreted by Kiley
APRN-supervised throughout — adjustments as needed
Medication as one tool within a comprehensive protocol
Goal: restore metabolic function for lasting results
The full program
Every tool working together
Medication addresses the physiological barriers. The rest of the program builds the foundation that makes results last.
Who this is for
You don't have to be where you want to be yet
Our program is for anyone ready to approach weight loss with clinical seriousness — whether you’re starting fresh or frustrated by programs that haven’t produced lasting results.
Chronic weight gain despite diet & exercise
Insulin resistance
Metabolic syndrome
Visceral fat accumulation
Type 2 diabetes or pre-diabetes
Perimenopausal weight changes
Post-menopausal weight gain
Elevated cardiovascular risk
High inflammatory markers
Hormonal-driven weight gain
Prior failed commercial programs
Wanting to avoid bariatric surgery
Getting started
What to expect
Every protocol begins with understanding your individual metabolic picture. Assessment comes before prescription — always.
Your visit
What to expect at your first appointment